CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
CPOM Optical Neuromonitordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03907904
NCT03907904N/ACompleted

Continuous, Non-invasive Monitoring of Intraoperative Cerebral Perfusion and Oxidative Metabolism (CPOM): a Knowledge Translation Study.

Western University, Canada·observational·Posted Apr 9, 2019·Updated Jan 27, 2025

In Brief

An observational study evaluating CPOM Optical Neuromonitor for Brain Hypoxia Ischemia. Completed, enrolled 50 participants across 1 site.

Detailed Summary

This study uses a CPOM Optical neuromonitor to assess the relationship between brain cytochrome C oxidase, cerebral oxygen saturation and blood pressure during surgery performed under general anesthesia.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedApr 9, 2019
Enrollment StartJul 1, 2019
Primary CompletionFeb 24, 2023
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 7.2 years ago

Interventions

CPOM Optical Neuromonitordevice

Prior to induction of anesthesia, the CPOM monitor will be secured to the temporal region of the participant's forehead to measure and record the cerebral hemodynamic data before, during, and following intubation. Hemodynamic, respiratory, body temperature, and anesthetic data will be continuously digitally records. The CPOM device will be detached after extubation in the operative room.